List of insiders holdings for Pacira BioSciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | GORDON CARL L Director |
2011-02-10 18:47:36 | 0 2,828,941 |
2,828,941 | Form 4 |
| 2 | KAILIAN VAUGHN M GADICKE ANSBERT Former 10% Owner |
2013-03-13 12:32:23 | 0 2,790,479 |
2,790,479 | Form 4 |
| 3 | HBM Healthcare Investments (Cayman) Ltd. 10% Owner |
2014-03-17 17:50:00 | 1,667,307 0 |
1,667,307 | Form 13D |
| 4 | ORBIMED ADVISORS LLC OrbiMed Capital GP III LLC ISALY SAMUEL D 10% Owner |
2012-09-28 17:25:59 | 1,620,000 0 |
1,620,000 | Form 13D |
| 5 | Sanderling Venture Partners VI LP Sanderling VI Beteiligungs GmbH & Co KG Sanderling Ventures Management VI Sanderling VI Limited Partnership SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP MIDDLETON FRED A 10% Owner |
2013-04-15 20:09:24 | 1,582,192 0 |
1,582,192 | Form 4/A |
| 6 | MPM BioVentures IV QP LP MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG DOMBKOWSKI ASHLEY L Vander Vort John Scopa James Paul St Peter Steven Greene William 10% Owner |
2013-03-21 16:20:40 | 1,420,406 0 |
1,420,406 | Form 13D |
| 7 | MPM BioVentures IV QP LP MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG Foley Todd Vander Vort John Scopa James Paul St Peter Steven 10% Owner |
2013-03-21 16:20:40 | 1,420,406 0 |
1,420,406 | Form 13D |
| 8 | MPM BioVentures IV QP LP Scopa James Paul MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG Foley Todd Vander Vort John Former 10% Owner |
2013-03-21 16:20:40 | 1,420,406 0 |
1,420,406 | Form 13D |
| 9 | EVNIN LUKE Director |
2013-06-13 15:52:10 | 7,000 824,255 |
831,255 | Form 4 |
| 10 | Sanderling Venture Partners VI LP Sanderling VI Beteiligungs GmbH & Co KG Sanderling VI Limited Partnership Sanderling Venture Partners VI Co Investment Fund LP MIDDLETON FRED A 10% Owner |
2013-04-15 20:10:26 | 602,286 0 |
602,286 | Form 4/A |
| 11 | STACK DAVID M CEO and Chairman |
2023-06-16 17:40:44 | 431,881 116,184 |
548,065 | Form 4 |
| 12 | Wicki Andreas Director |
2021-03-16 21:12:35 | 0 451,324 |
451,324 | Form 4 |
| 13 | Lee Frank D. Chief Executive Officer |
2025-02-04 18:25:44 | 448,409 0 |
448,409 | Form 4 |
| 14 | Cross Shawn Chief Financial Officer |
2024-11-05 16:42:18 | 275,000 0 |
275,000 | Form 4 |
| 15 | Pratt John General Manager, San Diego |
2013-06-14 18:29:44 | 261,982 0 |
261,982 | Form 4 |
| 16 | SLONIN JONATHAN Chief Medical Officer |
2025-02-04 18:26:04 | 187,044 0 |
187,044 | Form 4 |
| 17 | WILLIAMS KRISTEN Chief Administrative Officer |
2025-02-04 18:25:54 | 182,112 0 |
182,112 | Form 4 |
| 18 | Teehan Brendan Chief Commercial Officer |
2025-02-04 18:25:33 | 153,500 0 |
153,500 | Form 4 |
| 19 | GAUGLER DARYL Chief Operating Officer |
2025-01-06 18:22:59 | 115,443 0 |
115,443 | Form 4 |
| 20 | PATOU GARY Chief Medical Officer |
2014-08-08 16:31:55 | 80,453 702 |
81,155 | Form 4 |
| 21 | MIDDLETON FRED A Director |
2013-06-25 21:03:07 | 70,399 0 |
70,399 | Form 4 |
| 22 | Lambert William SVP, Pharmaceutical Dev |
2011-02-02 17:58:05 | 69,487 0 |
69,487 | Form 3 |
| 23 | Walters Mark SVP, Technicnical Operations |
2011-02-02 17:56:16 | 69,487 0 |
69,487 | Form 3 |
| 24 | RIKER LAUREN Senior Vice President, Finance |
2025-02-04 18:25:23 | 68,516 0 |
68,516 | Form 4 |
| 25 | Braunstein Scott Chief Operating Officer |
2018-01-05 19:47:10 | 60,000 0 |
60,000 | Form 4 |
| 26 | WINSTON ROY Chief Medical Officer |
2023-08-04 16:47:52 | 52,440 0 |
52,440 | Form 4 |
| 27 | Reinhart Charles A. III Chief Financial Officer |
2024-06-13 18:14:16 | 51,867 0 |
51,867 | Form 4 |
| 28 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer |
2022-06-16 16:05:51 | 50,752 0 |
50,752 | Form 4 |
| 29 | Manning Donald C. Chief Medical Officer |
2021-06-11 20:35:45 | 44,520 0 |
44,520 | Form 4 |
| 30 | McLoughlin Dennis Chief Customer Officer |
2023-06-07 21:24:37 | 38,115 0 |
38,115 | Form 4 |
| 31 | Kronenfeld Mark A. Director |
2024-06-13 18:12:24 | 37,081 0 |
37,081 | Form 4 |
| 32 | Scranton Richard Chief Scientific Officer |
2019-11-12 17:10:00 | 36,311 0 |
36,311 | Form 4 |
| 33 | Ellis Ronald J. Jr. Chief Strategy Officer |
2023-06-07 21:20:41 | 30,909 0 |
30,909 | Form 4 |
| 34 | REINHARDT MAX President, Rest of World |
2023-06-07 21:28:17 | 29,225 0 |
29,225 | Form 4 |
| 35 | Scibetta James S President |
2017-06-07 19:00:29 | 25,118 0 |
25,118 | Form 4 |
| 36 | HASTINGS PAUL J Director |
2024-06-13 18:13:00 | 24,903 0 |
24,903 | Form 4 |
| 37 | CHRISTIE CHRISTOPHER Director |
2024-06-13 18:14:46 | 22,670 0 |
22,670 | Form 4 |
| 38 | PACE GARY W Director |
2024-03-08 17:33:51 | 22,127 0 |
22,127 | Form 4 |
| 39 | Greenstreet Yvonne Director |
2022-06-08 19:26:28 | 21,472 0 |
21,472 | Form 4 |
| 40 | LONGENECKER JOHN P PHD Director |
2022-03-07 20:03:47 | 18,823 0 |
18,823 | Form 4 |
| 41 | Brege Laura Director |
2024-08-19 08:25:46 | 17,552 0 |
17,552 | Form 4 |
| 42 | Ceesay Abraham Director |
2024-06-13 18:13:47 | 17,409 0 |
17,409 | Form 4 |
| 43 | Young Alethia Director |
2024-06-13 18:13:14 | 17,409 0 |
17,409 | Form 4 |
| 44 | Jones James B SVP & Chief Medical Officer |
2017-11-20 18:43:53 | 16,823 0 |
16,823 | Form 4 |
| 45 | Froimson Mark Director |
2024-08-12 20:33:26 | 14,473 0 |
14,473 | Form 4 |
| 46 | MOLLOY ANTHONY Chief Lgl & Compliance Officer |
2023-06-07 21:26:59 | 12,877 0 |
12,877 | Form 4 |
| 47 | WINGER DENNIS L Director |
2017-06-16 20:18:24 | 10,204 0 |
10,204 | Form 4 |
| 48 | BIGAL MARCELO Director |
2024-08-19 08:25:55 | 10,142 0 |
10,142 | Form 4 |
| 49 | Markvicka Taunia SVP, Chief Commercial Officer |
2015-03-19 18:59:55 | 8,579 230 |
8,809 | Form 4 |
| 50 | YANG MICHAEL J. Director |
2024-08-14 16:35:09 | 7,230 0 |
7,230 | Form 4 |
| 51 | Weiland Robert J. Chief Commercial Officer |
2018-06-06 20:11:05 | 5,088 0 |
5,088 | Form 4 |